Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
America, Asia, baseline, Camargo, CHMP, COMMAND, converted, coverage, DLBCL, eligible, Epkinly, excessive, failed, flat, fourth, Helicobactor, HS, IMMpulse, insurance, Latin, list, losing, meet, MF, modified, monotherapy, navitoclax, Otezla, pay, percent, PsO, ranked, Regulation, ruxolitinib, Score, skin, Skinvive, Spleen, statistically, suppurativa, Symptom, wait, week, withdrew
Removed:
acquiring, appellate, Cook, Elliott, hereto, launch, Nakata, Shire, Supreme
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view